His Internal medicine study frequently draws connections to other fields, such as Concordance. In his articles, Michael Kneba combines various disciplines, including Oncology and Gastroenterology. Gastroenterology and Oncology are two areas of study in which he engages in interdisciplinary research. His Genetics study frequently draws connections to other fields, such as Gene rearrangement. He performs integrative Leukemia and Immunophenotyping research in his work. In his research, he performs multidisciplinary study on Immunophenotyping and Leukemia. His study deals with a combination of Gene and Germline mutation. Immunology and Antibody are two areas of study in which he engages in interdisciplinary work. In his research, Michael Kneba undertakes multidisciplinary study on Antibody and Rituximab.
His research links Cancer with Internal medicine. Much of his study explores Cancer relationship to Internal medicine. He performs multidisciplinary study in the fields of Oncology and Gastroenterology via his papers. With his scientific publications, his incorporates both Gastroenterology and Oncology. He conducts interdisciplinary study in the fields of Leukemia and Chronic lymphocytic leukemia through his research. In his works, Michael Kneba undertakes multidisciplinary study on Chronic lymphocytic leukemia and Leukemia. His study ties his expertise on Immunology together with the subject of Minimal residual disease. His work on Minimal residual disease expands to the thematically related Immunology. In his works, he performs multidisciplinary study on Genetics and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
J J M van Dongen;A W Langerak;M Brüggemann;P A S Evans.
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
Michael Hallek;K. Fischer;Gunter Fingerle-Rowson;A.M. Fink.
The Lancet (2010)
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
Wolfgang Hiddemann;Michael Kneba;Martin Dreyling;Norbert Schmitz.
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Valentin Goede;Kirsten Fischer;Raymonde Busch;Anja Engelke.
The New England Journal of Medicine (2014)
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Salah-Eddin Al-Batran;Nils Homann;Claudia Pauligk;Thorsten O Goetze.
The Lancet (2019)
Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
Max S. Topp;Peter Kufer;Nicola Gökbuget;Mariele Goebeler.
Journal of Clinical Oncology (2011)
Mutations driving CLL and their evolution in progression and relapse.
Dan A. Landau;Eugen Tausch;Amaro N. Taylor-Weiner;Chip Stewart.
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
J. Arends;G. Bodoky;F. Bozzetti;K.C. Fearon.
Clinical Nutrition (2006)
The landscape of genomic alterations across childhood cancers
Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: